Enrique Torrija, MD

Articles by Enrique Torrija, MD

UFT in Combination as Adjuvant Therapy for Breast Cancer

ByLuis Iglesias, MD,Jose A. Moreno, MD,Enrique Torrija, MD,Enrique Murillo, MD,Manuel Codes, MD,Antonio Duque, MD,Eduardo Garcia, MD,Jose A. Virizuela, MD

September 2nd 1997

Between 1989 and 1993, 409 evaluable patients with breast cancer have been treated with tegafur and uracil (UFT) in an adjuvant setting in two different trials. Data from both trials were reviewed in December 1995 after a

Latest Updated Articles

UFT in Combination as Adjuvant Therapy for Breast Cancer
September 2nd 1997

Trending on CancerNetwork

124 Real-World Progression-Free Survival 2 and Tumor Response of CDK4/6is + Aromatase Inhibitor in Patients With HR+/HER2– Metastatic Breast Cancer

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

123 Real-World Patient and Caregiver Experiences With Breast Cancer (BC) Risk of Recurrence (ROR) in the US: Results of an Online Survey and Social Media Analysis